These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 14729600

  • 21. High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread.
    Sato S, Kopitz C, Schmalix WA, Muehlenweg B, Kessler H, Schmitt M, Krüger A, Magdolen V.
    FEBS Lett; 2002 Sep 25; 528(1-3):212-6. PubMed ID: 12297307
    [Abstract] [Full Text] [Related]

  • 22. A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors.
    Solberg H, Rømer J, Brünner N, Holm A, Sidenius N, Danø K, Høyer-Hansen G.
    Int J Cancer; 1994 Sep 15; 58(6):877-81. PubMed ID: 7927882
    [Abstract] [Full Text] [Related]

  • 23. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors.
    Gutova M, Najbauer J, Frank RT, Kendall SE, Gevorgyan A, Metz MZ, Guevorkian M, Edmiston M, Zhao D, Glackin CA, Kim SU, Aboody KS.
    Stem Cells; 2008 Jun 15; 26(6):1406-13. PubMed ID: 18403751
    [Abstract] [Full Text] [Related]

  • 24. Asbestos upregulates expression of the urokinase-type plasminogen activator receptor on mesothelial cells.
    Perkins RC, Broaddus VC, Shetty S, Hamilton S, Idell S.
    Am J Respir Cell Mol Biol; 1999 Nov 15; 21(5):637-46. PubMed ID: 10536123
    [Abstract] [Full Text] [Related]

  • 25. Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts.
    Rofstad EK, Tunheim SH, Mathiesen B, Graff BA, Halsør EF, Nilsen K, Galappathi K.
    Cancer Res; 2002 Feb 01; 62(3):661-4. PubMed ID: 11830516
    [Abstract] [Full Text] [Related]

  • 26. Analysis of expressions of components in the plasminogen activator system in high- and low-metastatic human lung cancer cells.
    He C, He P, Liu LP, Zhu YS.
    J Cancer Res Clin Oncol; 2001 Feb 01; 127(3):180-6. PubMed ID: 11260863
    [Abstract] [Full Text] [Related]

  • 27. Monitoring of tumor reoxygenation following irradiation by 31P magnetic resonance spectroscopy: an experimental study of human melanoma xenografts.
    Olsen DR, Rofstad EK.
    Radiother Oncol; 1999 Sep 01; 52(3):261-7. PubMed ID: 10580874
    [Abstract] [Full Text] [Related]

  • 28. Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8.
    Rofstad EK, Halsør EF.
    Br J Cancer; 2002 Jan 21; 86(2):301-8. PubMed ID: 11870523
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro.
    Stahl A, Mueller BM.
    Cancer Res; 1994 Jun 01; 54(11):3066-71. PubMed ID: 8187097
    [Abstract] [Full Text] [Related]

  • 31. Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.
    Yang JL, Seetoo Dq, Wang Y, Ranson M, Berney CR, Ham JM, Russell PJ, Crowe PJ.
    Int J Cancer; 2000 Sep 20; 89(5):431-9. PubMed ID: 11008205
    [Abstract] [Full Text] [Related]

  • 32. Suppression of urokinase receptor expression by thalidomide is associated with inhibition of nuclear factor kappaB activation and subsequently suppressed ovarian cancer dissemination.
    Kobayashi H, Yagyu T, Kondo T, Kurita N, Inagaki K, Haruta S, Kawaguchi R, Kitanaka T, Sakamoto Y, Yamada Y, Kanayama N, Terao T.
    Cancer Res; 2005 Nov 15; 65(22):10464-71. PubMed ID: 16288038
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Expression of urokinase-type plasminogen activator receptor and plasminogen activator inhibitor-1 in gastric cancer.
    Kawasaki K, Hayashi Y, Wang Y, Suzuki S, Morita Y, Nakamura T, Narita K, Doe W, Itoh H, Kuroda Y.
    J Gastroenterol Hepatol; 1998 Sep 15; 13(9):936-44. PubMed ID: 9794194
    [Abstract] [Full Text] [Related]

  • 37. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 38. A Cross Talk between Neuronal Urokinase-type Plasminogen Activator (uPA) and Astrocytic uPA Receptor (uPAR) Promotes Astrocytic Activation and Synaptic Recovery in the Ischemic Brain.
    Diaz A, Merino P, Manrique LG, Ospina JP, Cheng L, Wu F, Jeanneret V, Yepes M.
    J Neurosci; 2017 Oct 25; 37(43):10310-10322. PubMed ID: 28931568
    [Abstract] [Full Text] [Related]

  • 39. Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor.
    Montuori N, Salzano S, Rossi G, Ragno P.
    FEBS Lett; 2000 Jul 07; 476(3):166-70. PubMed ID: 10913606
    [Abstract] [Full Text] [Related]

  • 40. Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination.
    Rofstad EK, Gaustad JV, Egeland TA, Mathiesen B, Galappathi K.
    Int J Cancer; 2010 Oct 01; 127(7):1535-46. PubMed ID: 20091868
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.